Yayınlar & Eserler

Yayın Ağı
Makaleler 13
Tümü (13)
SCI-E, SSCI, AHCI (12)
SCI-E, SSCI, AHCI, ESCI (12)
Scopus (13)
TRDizin (1)

1. Epidemiology and Clinical Profiles of Bacteroides fragilis Bacteremia in a Tertiary Care Setting: A 5-Year Review

SÖNMEZER M. Ç., ERUL E., Aka Türkmen N., ŞAHİN T. K., Demir Cuha M., HAZIROLAN G., et al.
Canadian Journal of Infectious Diseases and Medical Microbiology , cilt.2026, sa.1, 2026 (SCI-Expanded, Scopus)

2. The Efficacy of Immune Checkpoint Inhibitors in Microsatellite Stable Colorectal Cancer: A Systematic Review

GÜVEN D. C., KAVGACI G., ERUL E., Syed M. P., Magge T., Saeed A., et al.
ONCOLOGIST , cilt.29, 2024 (SCI-Expanded, Scopus) Creative Commons License Sürdürülebilir Kalkınma

3. Immune checkpoint inhibitor-related hearing loss: a systematic review and analysis of individual patient data

Guven D. C., ERUL E., KAYGUSUZ Y., Akagunduz B., Kilickap S., De Luca R., et al.
Supportive Care in Cancer , cilt.31, sa.12, 2023 (SCI-Expanded, Scopus)

4. Role of sarcopenia on survival and treatment-related toxicity in head and neck cancer: a narrative review of current evidence and future perspectives

ERUL E., GÜVEN D. C., ONUR M. R., YAZICI G., AKSOY S.
European Archives of Oto-Rhino-Laryngology , cilt.280, sa.8, ss.3541-3556, 2023 (SCI-Expanded, Scopus)

5. The incidence and risk factors for acute kidney injury in patients treated with immune checkpoint inhibitors

GÜVEN D. C., ÖZBEK D. A., ŞAHİN T. K., KAVGACI G., Aksun M. S., ERUL E., et al.
Anti-Cancer Drugs , cilt.34, sa.6, ss.783-790, 2023 (SCI-Expanded, Scopus)

6. The association between pan-immune-inflammation value and survival in head and neck squamous cell carcinoma

GÜVEN D. C., ERUL E., YILMAZ F., YAŞAR S., YILDIRIM H. Ç., ERCAN F., et al.
European Archives of Oto-Rhino-Laryngology , cilt.280, sa.5, ss.2471-2478, 2023 (SCI-Expanded, Scopus)

7. Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer

Kahraman S., ERUL E., Seyyar M., GÜMÜŞAY Ö., Bayram E., Demirel B. C., et al.
Future oncology (London, England) , cilt.19, sa.10, ss.727-736, 2023 (SCI-Expanded, Scopus)

8. Optimal adjuvant treatment strategies for TNBC patients with residual disease after neoadjuvant treatment

Guven D. C., YILDIRIM H. Ç., KUŞ F., Erul E., KERTMEN N., DİZDAR Ö., et al.
Expert Review of Anticancer Therapy , cilt.23, sa.10, ss.1049-1059, 2023 (SCI-Expanded, Scopus)

9. Evaluation of sarcopenia as a prognostic biomarker in locally advanced head and neck squamous cell carcinoma

ERUL E., Guven D. C., ÖZBAY Y., ALTUNBULAK A. Y., KAHVECİOĞLU A., ERCAN F., et al.
Biomarkers in medicine , cilt.17, sa.2, ss.87-99, 2023 (SCI-Expanded, Scopus)

10. Knowledge and Attitudes of Turkish Physicians towards Human Monkeypox Disease and Related Vaccination: A Cross-Sectional Study

ŞAHİN T. K., ERUL E., AKSUN M. S., SÖNMEZER M. Ç., ÜNAL S., AKOVA M.
Vaccines , cilt.11, sa.1, 2023 (SCI-Expanded, Scopus) Creative Commons License

11. The association between albumin levels and survival in patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis

GÜVEN D. C., ŞAHİN T. K., ERUL E., Rizzo A., Ricci A. D., AKSOY S., et al.
Frontiers in Molecular Biosciences , cilt.9, 2022 (SCI-Expanded, Scopus) Creative Commons License

12. The use of fulvestrant before chemotherapy improves survival in hormone-positive breast cancer: a real-life study

GÜVEN D. C., YILDIRIM H. Ç., ERUL E., ŞAHİN T. K., ÇAKIR İ. Y., AKTEPE O. H., et al.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.52, sa.5, ss.1551-1558, 2022 (SCI-Expanded, Scopus, TRDizin) Creative Commons License

13. Behçet's Disease-related Budd–Chiari Syndrome Successfully Managed with anti-TNF Antibody: A Case Report and Review of the Literature

ERUL E., Uzun G. S., KÖKSAL D., KESKİN O., UYSAL S., İNKAYA A. Ç., et al.
European Journal of Case Reports in Internal Medicine , cilt.9, sa.8, 2022 (Scopus) Creative Commons License
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 2

1. Immunogenicity of two doses of inactive COVID-19 vaccine and third booster dose mRNA vaccine in patients with cancer receiving active systemic therapy

GÜVEN D. C., Incesu F. G. G., Yildirim H. C., Erul E., Chalabiyev E., AKTAŞ B. Y., et al.
Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), ELECTR NETWORK, 9 - 13 Eylül 2022, cilt.33, (Özet Bildiri)

2. Amyloidosis in Behcet’s Disease: Experience of a Vasculitis Centre at Silk Road

BÖLEK E. Ç., ERUL M. E., YARDIMCI G. K., KILIÇ L., AKDOĞAN A., KARADAĞ Ö.
2019 ACR/ARP Annual Meeting, ATLANTA, Amerika Birleşik Devletleri, 8 - 13 Kasım 2019, (Özet Bildiri)
Metrikler

Yayın

15

Yayın (WoS)

13

Yayın (Scopus)

13

Atıf (WoS)

106

H-İndeks (WoS)

4

Atıf (Scopus)

349

H-İndeks (Scopus)

5

Açık Erişim

5
BM Sürdürülebilir Kalkınma Amaçları
SDG 3: AMAÇ 3: SAĞLIKLI BİREYLER